37 completed. 37 Phase 1, 9 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 37 | Completed 37 |
| Phase 2 | 9 | Completed 9 |
Follow PET Scan: new trials by email Literature Review of PET Scan trials Research Report on PET Scan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Vitamin D in OUD: Exploration of Alterations on the Dopamine D2/D3 Receptor System [11C]-PHNO, Calcitriol, Placebo Control - Opioid Use Disorder | Phase 1 | Completed | Yale University | 5 | 2024-03-13 | 2025-11-14 |
| Siltuximab for the Prevention of CAR T Cell Related Cytokine Release Syndrome in Patients With CD19 Positive Non-Hodgkin Lymphoma Biospecimen Collection, Computed Tomography, Positron Emission Tomography - Non-Hodgkin Lymphoma | Phase 1 | Completed | Timothy Voorhees | 11 | 2023-01-31 | 2025-01-31 |
| NKTR-255 in Combination With CAR-T Cell Therapy for the Treatment of Relapsed or Refractory Large B-cell Lymphoma Cyclophosphamide, Fludarabine, Lisocabtagene Maraleucel - Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Phase 1 | Completed | Fred Hutchinson Cancer Center | 27 | 2022-12-08 | 2026-09-21 |
| PET Imaging of Vaso-Occlusive Crisis (VOC) in SCD Positron Emission Tomography, Cu-64]-LLP2A - Sickle Cell Disease | Phase 1 | Completed | Enrico Novelli | 15 | 2022-11-11 | 2026-08-18 |
| Imaging of Pathologic Fibrosis Using 68Ga-FAP-2286 68Ga-FAP-2286, Positron Emission Tomography (PET) - Liver Fibrosis, Pulmonary Fibrosis | Phase 1 | Completed | Thomas Hope | 16 | 2021-12-09 | 2025-03-21 |
| An Investigational Scan (rh PSMA 7.3 PET/MRI) for the Detection of Recurrent Disease and Aid in Radiotherapy Planning in Biochemically Recurrent Prostate Cancer Fluorine F 18 rhPSMA-7.3, Magnetic Resonance Imaging, Positron Emission Tomography - Biochemically Recurrent Prostate Carcinoma, Localized Prostate Carcinoma | Phase 1 | Completed | M.D. Anderson Cancer Center | 29 | 2021-08-04 | 2024-10-23 |
| Fluciclovine and PSMA PET/CT for the Classification and Improved Staging of Invasive Lobular Breast Cancer Computed Tomography, Fluciclovine F18, Gallium Ga 68 Gozetotide - Anatomic Stage IV Breast Cancer AJCC v8, Invasive Breast Lobular Carcinoma | Phase 1 | Completed | Emory University | 20 | 2021-07-16 | 2025-01-17 |
| M1 Schizophrenia PET Study 11C-EMO - A Novel PET Radiotracer for Muscarinic M1 Receptor, PET Scan - Schizophrenia, Schizoaffective Disorder | Phase 1 | Completed | Yale University | 18 | 2021-04-20 | 2024-11-12 |
| An Imaging Agent (I-124 M5A) in Detecting CEA-Positive Liver Metastases in Patients With Colorectal Cancer Iodine I 124 Monoclonal Antibody M5A, Positron Emission Tomography - Colorectal Carcinoma Metastatic in the Liver, Metastatic Colorectal Carcinoma | Phase 1 | Completed | City of Hope Medical Center | 4 | 2020-07-15 | 2024-06-28 |
| 68Ga-PSMA-11 PET for the Diagnosis of Biochemically Recurrent Prostate Cancer Gallium Ga 68-labeled PSMA-11, Positron Emission Tomography - Biochemically Recurrent Prostate Carcinoma | Phase 1 | Completed | City of Hope Medical Center | 19 | 2019-12-19 | 2026-10-23 |
| 68-Ga-RM2 PET/MRI in Imaging Patients With Estrogen Receptor-Positive Breast Cancer Gallium Ga 68-labeled GRPR Antagonist BAY86-7548, Magnetic Resonance Imaging, Positron Emission Tomography - Breast Carcinoma, Estrogen Receptor Positive | Phase 1 / Phase 2 | Completed | Andrei Iagaru | 5 | 2019-03-19 | 2023-12-13 |
| Gallium Ga 68-DOTATATE PET/CT in Predicting Tumor Growth in Patients With Meningiomas Computed Tomography, Gallium Ga 68-DOTATATE, Positron Emission Tomography - Meningioma | Phase 1 | Completed | M.D. Anderson Cancer Center | 13 | 2019-01-10 | 2023-09-01 |
| M7824 and Topotecan or Temozolomide in Relapsed Small Cell Lung Cancers M7824, Topotecan, Temozolomide - Carcinoma, Small Cell, Lung Cancer | Phase 1 / Phase 2 | Completed | National Cancer Institute (NCI) | 37 | 2018-09-11 | 2025-05-09 |
| Quantitative Mapping of Substantia Nigra Iron in Parkinson's Disease (Stages I-IV, REM Sleep Behavior Disorder) and Controls (11C)PE2I, Ioflupane - Parkinson Disease, REM Sleep Behavior Disorder | Phase 1 / Phase 2 | Completed | Weill Medical College of Cornell University | 82 | 2018-08-14 | 2025-03-12 |
| Fludeoxyglucose F-18-PET in Planning Lung Cancer Radiation Therapy Fludeoxyglucose F-18, Positron Emission Tomography (PET), Stereotactic Body Radiation Therapy (SBRT) - Stage I Lung Cancer, Stage I Non-Small Cell Lung Cancer AJCC v7 | Phase 1 | Completed | Emory University | 19 | 2018-04-13 | 2023-10-18 |
| Copper 64Cu-DOTA-Daratumumab Positron Emission Tomography in Diagnosing Patients With Relapsed Multiple Myeloma Daratumumab, Imaging Agent, Positron Emission Tomography - Recurrent Plasma Cell Myeloma, Plasma Cell Myeloma | Phase 1 | Completed | City of Hope Medical Center | 12 | 2018-02-21 | 2024-03-12 |
| Vitamin D as a Therapeutic Adjunct in the Stimulant Treatment of ADHD Magnetic Resonance Imaging (MRI), PHNO, calcitriol - ADHD | Phase 1 | Completed | Yale University | 24 | 2017-08-15 | 2024-03-19 |
| Gene-Modified T Cells, Vaccine Therapy, and Nivolumab in Treating Patients With Stage IV or Locally Advanced Solid Tumors Expressing NY-ESO-1 Aldesleukin, Cyclophosphamide, Fludarabine Phosphate - Adult Solid Neoplasm, Childhood Solid Neoplasm | Phase 1 | Completed | Jonsson Comprehensive Cancer Center | 1 | 2017-01-03 | 2025-07-30 |
| Pembrolizumab, Combination Chemotherapy, and Radiation Therapy Before Surgery in Treating Adult Patients With Locally Advanced Gastroesophageal Junction or Gastric Cardia Cancer That Can Be Removed by Surgery Carboplatin, Computed Tomography, Fluorouracil - Gastric Cardia Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma | Phase 1 / Phase 2 | Completed | Mayo Clinic | 31 | 2016-06-24 | 2025-06-22 |
| Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer Antiretroviral Therapy, Biopsy, Biospecimen Collection - AIDS-Related Non-Hodgkin Lymphoma, Clinical Stage III Cutaneous Melanoma AJCC v8 | Phase 1 | Completed | National Cancer Institute (NCI) | 58 | 2016-04-04 | 2024-08-09 |
Showing 20 of 37. Sign in to see all of them.
Lymphoma, Non-Hodgkin (4) · Glioblastoma (3) · Lung Neoplasms (3) · Prostatic Neoplasms (3) · Astrocytoma (2) · Carcinoma, Non-Small-Cell Lung (2) · Carcinoma, Renal Cell (2) · Gliosarcoma (2) · Lymphoma, Large B-Cell, Diffuse (2) · Meningioma (2) · Neoplasm Metastasis (2) · Neoplasms (2) · Oligodendroglioma (2) · Stomach Neoplasms (2) · Adenocarcinoma Of Esophagus (1)
National Cancer Institute (NCI) (9) · City of Hope Medical Center (4) · M.D. Anderson Cancer Center (3) · Yale University (3) · Emory University (2) · Mayo Clinic (2) · Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (2) · Andrei Iagaru (1) · Barbara Ann Karmanos Cancer Institute (1) · Enrico Novelli (1) · Fred Hutchinson Cancer Center (1) · Jonsson Comprehensive Cancer Center (1) · Memorial Sloan Kettering Cancer Center (1) · National Institute of Mental Health (NIMH) (1) · Stanford University (1)
United States (37) · Canada (1) · Japan (1) · South Korea (1)
Andrei Iagaru (2) · Glenn Liu (2) · Alexander Shtilbans, MD (1) · Alexandre Hirayama (1) · Amrita Krishnan, MD (1) · Anish Thomas, M.D. (1) · Antoni Ribas (1) · Arthur Blackstock (1) · Behnam Badie (1) · Charles Erlichman, M.D. (1) · David M Schuster, MD (1) · Devaki Shilpa S Surasi (1) · Elizabeth R Gerstner, MD (1) · Enrico Novelli, MD, MS (1) · Harry H. Yoon, M.D. (1)
PMID 24309981, PMID 25113840, PMID 26659347, PMID 27725657, PMID 31154457, PMID 33095874, PMID 33842889, PMID 35080914, PMID 37156551, PMID 38197800, PMID 38976035, PMID 39356983, PMID 41680482, PMID 42820295
P30CA014520 (2), P30CA022453 (2), P30CA138292 (2), U01CA062491 (2), K12HD000850 (1), P30CA006516 (1), P30CA015704 (1), P30CA033572 (1), P30CA124435 (1), R01AT010508 (1), R01CA129371 (1), R01HL154629 (1), R01MH113557 (1), R01NS095562 (1), R21MH123870 (1)